Literature DB >> 8645886

Allogeneic microchimerism and donor antigen-specific hyporeactivity in lung transplant recipients.

C McSherry1, M I Hertz, A M Jackson, K Butters, M Diko, A J Matas, R M Bolman, N L Reinsmoen.   

Abstract

The identification of peripheral donor cells in solid organ transplant recipients has led to speculation as to the tolerogenic role of circulating donor cells. Also being debated is the possible significance of persistent donor alloantigen-presenting cells in inducing and maintaining an alloantigen-specific unresponsive state. Previously, we showed that donor antigen-specific hyporeactivity is a useful marker for identifying kidney, lung, or heart recipients at low risk for immunologic complications; we found donor antigen-specific hyporeactivity in 25% of kidney, 35% of lung, and 22% of heart recipients. All 3 hyporeactive subgroups experienced fewer late (> 3 months) rejection episodes and a lower incidence of chronic rejection. The purpose of the current study was to determine whether peripheral blood microchimerism correlates with the development of donor antigen-specific hyporeactivity and affects clinical outcome. We correlated the detection of microchimerism with in vitro proliferative response to donor antigen in 19 lung recipients who were > or = 12 months posttransplant. Allogeneic peripheral blood microchimerism was studied with a PCR-based limiting detection assay using HLA-DR sequence-specific primers. We detected microchimerism in 47% (9 of 19) of the lung recipients tested. All recipients who were donor antigen-specific hyporesponsive had microchimerism, and all recipients without detectable microchimerism were responsive to donor antigen. However, not all recipients with microchimerism developed donor antigen-specific hyporeactivity. Further, none of the hyporesponsive recipients has been diagnosed with obliterative bronchiolitis (OB). In contrast, 2 of the 4 with microchimerism who were responsive to donor antigen have been diagnosed with OB, as have 5 of the 10 who were negative for both hyporeactivity and microchimerism. Thus, long-term graft outcome may correlate more closely with donor antigen-specific hyporeactivity than with microchimerism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8645886

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  4 in total

Review 1.  Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.

Authors:  A J Demetris; N Murase; R G Lee; P Randhawa; A Zeevi; S Pham; R Duquesnoy; J J Fung; T E Starzl
Journal:  Ann Transplant       Date:  1997       Impact factor: 1.530

2.  Concordance of genotypes in pre- and post-lung transplantation DNA samples.

Authors:  Dawn L DeMeo; John J Reilly; Leo C Ginns; Jody S Sylvia; Edwin K Silverman
Journal:  Am J Respir Cell Mol Biol       Date:  2005-06-30       Impact factor: 6.914

3.  A clinical trial combining donor bone marrow infusion and heart transplantation: intermediate-term results.

Authors:  S M Pham; A S Rao; A Zeevi; R L Kormos; K R McCurry; B G Hattler; J J Fung; T E Starzl; B P Griffith
Journal:  J Thorac Cardiovasc Surg       Date:  2000-04       Impact factor: 5.209

4.  Simultaneous bone marrow and composite tissue transplantation in rats treated with nonmyeloablative conditioning promotes tolerance.

Authors:  Hong Xu; Deborah M Ramsey; Shengli Wu; Larry D Bozulic; Suzanne T Ildstad
Journal:  Transplantation       Date:  2013-01-27       Impact factor: 4.939

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.